热门资讯> 正文

Cypherpunk Technology GAAP每股收益为-0.08美元

2025-11-12 22:19

Leap Therapeutics(LPTX) 0

Cypherpunk Technologies press release (LPTX): Q3 GAAP EPS of -$0.08.
Cash and cash equivalents totaled $9.7 million on September 30, 2025, prior to the completion of the $58.88 million private placement that closed in October 2025.

More on Cypherpunk Technologies

Leap Therapeutics secures $58.9M PIPE to launch digital asset strategy; shares up 29%
Seeking Alpha’s Quant Rating on Cypherpunk Technologies
Historical earnings data for Cypherpunk Technologies
Financial information for Cypherpunk Technologies

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。